X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1021) 1021
Publication (96) 96
Book Review (5) 5
Conference Proceeding (3) 3
Book Chapter (2) 2
Book / eBook (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (813) 813
male (609) 609
female (545) 545
middle aged (429) 429
index medicus (413) 413
aged (353) 353
adult (347) 347
esophagogastric junction (336) 336
gastroenterology & hepatology (259) 259
esophagogastric junction - pathology (242) 242
oncology (241) 241
cancer (232) 232
animals (228) 228
esophageal neoplasms - pathology (198) 198
esophagogastric junction - metabolism (194) 194
adenocarcinoma (184) 184
surgery (180) 180
immunohistochemistry (160) 160
esophagogastric junction - drug effects (158) 158
adenocarcinoma - pathology (154) 154
esophageal neoplasms - metabolism (154) 154
stomach neoplasms - pathology (143) 143
prognosis (142) 142
aged, 80 and over (141) 141
esophageal cancer (140) 140
adenocarcinoma - metabolism (139) 139
esophagogastric junction - physiology (134) 134
treatment outcome (131) 131
chemotherapy (127) 127
stomach neoplasms - metabolism (127) 127
esophagogastric junction - physiopathology (124) 124
pressure (119) 119
esophagus (118) 118
stomach neoplasms - drug therapy (107) 107
pathology (102) 102
manometry (100) 100
gastric cancer (95) 95
medicine & public health (95) 95
gastroesophageal reflux - physiopathology (91) 91
hydrogen-ion concentration (90) 90
research (90) 90
esophageal neoplasms - drug therapy (89) 89
carcinoma (88) 88
neoplasm staging (88) 88
barretts-esophagus (87) 87
care and treatment (84) 84
gastroesophageal reflux (82) 82
analysis (79) 79
barrett esophagus - pathology (79) 79
esophagus - metabolism (79) 79
antineoplastic combined chemotherapy protocols - therapeutic use (78) 78
esophageal neoplasms - surgery (78) 78
gastroesophageal junction (77) 77
barrett esophagus - metabolism (76) 76
esophageal neoplasms - mortality (75) 75
lower esophageal sphincter (73) 73
squamous-cell carcinoma (72) 72
adenocarcinoma - drug therapy (71) 71
receptor, erbb-2 - metabolism (71) 71
tumors (71) 71
biomarkers, tumor - metabolism (70) 70
stomach cancer (70) 70
esophagogastric junction - surgery (69) 69
adenocarcinoma - mortality (67) 67
expression (67) 67
retrospective studies (67) 67
neoadjuvant therapy (63) 63
survival (62) 62
esophageal neoplasms - therapy (61) 61
pharmacology & pharmacy (61) 61
prospective studies (61) 61
health aspects (60) 60
stomach neoplasms - genetics (60) 60
antineoplastic agents - therapeutic use (59) 59
stomach neoplasms - mortality (59) 59
in vitro techniques (57) 57
adenocarcinoma - surgery (56) 56
follow-up studies (56) 56
gastroesophageal reflux - metabolism (55) 55
intestinal metaplasia (55) 55
gastroenterology (54) 54
adenocarcinoma - genetics (53) 53
positron-emission-tomography (53) 53
esophageal neoplasms - genetics (52) 52
abridged index medicus (51) 51
esophageal neoplasms - diagnosis (51) 51
barrett's esophagus (50) 50
biopsy (50) 50
survival rate (50) 50
time factors (50) 50
breast-cancer (48) 48
gastric acid - metabolism (48) 48
survival analysis (48) 48
diagnosis (47) 47
gene amplification (47) 47
muscle contraction - drug effects (47) 47
advanced esophagogastric cancer (46) 46
cats (46) 46
fluorodeoxyglucose f18 (46) 46
chemoradiotherapy (45) 45
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1000) 1000
Chinese (10) 10
Japanese (10) 10
German (7) 7
Spanish (4) 4
French (1) 1
Polish (1) 1
Russian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 10/2017, Volume 550, Issue 7677, pp. 529 - 533
Journal Article
Cancer, ISSN 0008-543X, 02/2007, Volume 109, Issue 4, pp. 658 - 667
Journal Article
PLOS ONE, ISSN 1932-6203, 04/2019, Volume 14, Issue 4, p. e0215089
Aim Barrett's esophagus (BE) is a predisposing factor of esophageal adenocarcinoma/gastroesophageal junction adenocarcinoma (ECA/GEJ Aca). BE patients are... 
DIAGNOSIS | ENDOSCOPY | LOW-GRADE DYSPLASIA | LIVER-INTESTINE-CADHERIN | INHIBITION | MANAGEMENT | MULTIDISCIPLINARY SCIENCES | SUBCELLULAR-LOCALIZATION | SURVEILLANCE | BARRETTS-ESOPHAGUS | TUMOR-SUPPRESSIVE MASPIN | Barrett Esophagus - metabolism | Adenocarcinoma - pathology | Metaplasia - metabolism | Serpins - metabolism | Humans | Esophagogastric Junction - metabolism | Esophagogastric Junction - pathology | Esophagus - metabolism | Precancerous Conditions - metabolism | Case-Control Studies | Disease Progression | Esophageal Neoplasms - pathology | Metaplasia - pathology | Esophagus - pathology | Adenocarcinoma - metabolism | Barrett Esophagus - pathology | Esophageal Neoplasms - metabolism | Biomarkers, Tumor - metabolism | Precancerous Conditions - pathology | Patient outcomes | Development and progression | Genetic aspects | Research | Gene expression | Esophageal cancer | Risk factors | Adenocarcinoma | Ethylenediaminetetraacetic acid | Dysplasia | Analysis | Diagnosis | Endoscopy | Tumor proteins | Immunohistochemistry | p53 Protein | Lung cancer | Staining | Oncology | Biology | Malignancy | Proteins | Histopathology | Endoscopes | Intestine | Mastectomy | Lesions | Localization | Distribution patterns | Gastroesophageal reflux | Statistical analysis | Breast cancer | Medical screening | Patients | Esophagus | Medicine | Pathology | Metaplasia | Surveillance | Biopsy | Medical prognosis | Epigenetics | Tumor suppressor genes | Diagnostic systems | Tumors
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 4/2014, Volume 73, Issue 4, pp. 737 - 747
The aim of this study was to characterize trastuzumab population pharmacokinetics (PKs) in patients with human epidermal growth factor receptor 2-positive... 
Population pharmacokinetics | Gastroesophageal junction cancer | Medicine & Public Health | Exposure–response | Oncology | Cancer Research | Pharmacology/Toxicology | Gastric cancer | Trastuzumab | Exposure-response | SURVIVAL | EGF | RECEPTOR | HER-2 | AMPLIFICATION | GENE | ONCOLOGY | PHARMACOLOGY & PHARMACY | rastuzumab | Receptor, ErbB-2 - genetics | Capecitabine | Esophageal Neoplasms - blood | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Receptor, ErbB-2 - metabolism | Stomach Neoplasms - metabolism | Male | Stomach Neoplasms - pathology | Cisplatin - administration & dosage | Esophageal Neoplasms - pathology | Young Adult | Antibodies, Monoclonal, Humanized - administration & dosage | Fluorouracil - administration & dosage | Antibodies, Monoclonal, Humanized - pharmacokinetics | Antibodies, Monoclonal, Humanized - blood | Esophageal Neoplasms - metabolism | Aged, 80 and over | Adult | Female | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Esophagogastric Junction - metabolism | Esophagogastric Junction - pathology | Stomach Neoplasms - drug therapy | Stomach Neoplasms - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged | Esophageal Neoplasms - drug therapy | Deoxycytidine - analogs & derivatives | Antimitotic agents | Care and treatment | Chemotherapy | Epidermal growth factor | Analysis | Antineoplastic agents | Cancer
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2016, Volume 11, Issue 8, p. e0161781
Journal Article
Journal Article